{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:35:33Z","timestamp":1758807333961},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,12,24]],"date-time":"2010-12-24T00:00:00Z","timestamp":1293148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s10096-010-1129-2","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T19:37:41Z","timestamp":1293133061000},"page":"611-618","source":"Crossref","is-referenced-by-count":14,"title":["Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients"],"prefix":"10.1007","volume":"30","author":[{"given":"A.","family":"Meerveld-Eggink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Weerdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M.","family":"Voer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A. M.","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Velzen-Blad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. J.","family":"Vlaminckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. H.","family":"Biesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. T.","family":"Rijkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,24]]},"reference":[{"key":"1129_CR1","unstructured":"[No authors listed] (1997) Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 46(RR-8):1\u201324"},{"key":"1129_CR2","unstructured":"[No authors listed] (1996) Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. BMJ 312(7028):430\u2013434"},{"issue":"5","key":"1129_CR3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7861\/clinmedicine.2-5-440","volume":"2","author":"JM Davies","year":"2002","unstructured":"Davies JM, Barnes R, Milligan D; British Committee for Standards in Haematology. Working Party of the Haematology\/Oncology Task Force (2002) Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med 2(5):440\u2013443","journal-title":"Clin Med"},{"issue":"RR-7","key":"1129_CR4","first-page":"1","volume":"54","author":"OO Bilukha","year":"2005","unstructured":"Bilukha OO, Rosenstein N; National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) (2005) Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54(RR-7):1\u201321","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"1129_CR5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.inf.0000129686.12470.e6","volume":"23","author":"DM Granoff","year":"2004","unstructured":"Granoff DM, Harris SL (2004) Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine. Pediatr Infect Dis J 23(6):490\u2013497","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1129_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.inf.0000195594.41449.c6","volume":"25","author":"SC Greeff de","year":"2006","unstructured":"de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A (2006) Protection from routine vaccination at the age of 14\u00a0months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J 25(1):79\u201380","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"1129_CR7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/infdis\/141.3.404","volume":"141","author":"GS Giebink","year":"1980","unstructured":"Giebink GS, Foker JE, Kim Y, Schiffman G (1980) Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J Infect Dis 141(3):404\u2013412","journal-title":"J Infect Dis"},{"issue":"8057","key":"1129_CR8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0140-6736(78)90612-8","volume":"1","author":"JL Sullivan","year":"1978","unstructured":"Sullivan JL, Ochs HD, Schiffman G, Hammerschlag MR, Miser J, Vichinsky E et al (1978) Immune response after splenectomy. Lancet 1(8057):178\u2013181","journal-title":"Lancet"},{"issue":"7\u20138","key":"1129_CR9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00508-006-0752-5","volume":"119","author":"K Eigenberger","year":"2007","unstructured":"Eigenberger K, Sillaber C, Greitbauer M, Herkner H, Wolf H, Graninger W et al (2007) Antibody responses to pneumococcal and hemophilus vaccinations in splenectomized patients with hematological malignancies or trauma. Wien Klin Wochenschr 119(7\u20138):228\u2013234","journal-title":"Wien Klin Wochenschr"},{"issue":"29","key":"1129_CR10","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1016\/j.vaccine.2007.05.014","volume":"25","author":"F Smets","year":"2007","unstructured":"Smets F, Bourgois A, Vermylen C, Brichard B, Slacmuylders P, Leyman S et al (2007) Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine. Vaccine 25(29):5278\u20135282","journal-title":"Vaccine"},{"issue":"2","key":"1129_CR11","first-page":"45","volume":"62","author":"DC Melles","year":"2004","unstructured":"Melles DC, de Marie S (2004) Prevention of infections in hyposplenic and asplenic patients: an update. Neth J Med 62(2):45\u201352","journal-title":"Neth J Med"},{"issue":"12","key":"1129_CR12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1198-743x.2001.00355.x","volume":"7","author":"RN Davidson","year":"2001","unstructured":"Davidson RN, Wall RA (2001) Prevention and management of infections in patients without a spleen. Clin Microbiol Infect 7(12):657\u2013660","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"1129_CR13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/323648","volume":"184","author":"T Wuorimaa","year":"2001","unstructured":"Wuorimaa T, Dagan R, V\u00e4kev\u00e4inen M, Bailleux F, Haikala R, Yaich M et al (2001) Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant. J Infect Dis 184(9):1211\u20131215","journal-title":"J Infect Dis"},{"issue":"4","key":"1129_CR14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/CVI.00241-06","volume":"14","author":"SL Harris","year":"2007","unstructured":"Harris SL, Tsao H, Ashton L, Goldblatt D, Fernsten P (2007) Avidity of the immunoglobulin G response to a Neisseria meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays. Clin Vaccine Immunol 14(4):397\u2013403","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"1129_CR15","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","volume":"177","author":"D Goldblatt","year":"1998","unstructured":"Goldblatt D, Vaz AR, Miller E (1998) Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 177(4):1112\u20131115","journal-title":"J Infect Dis"},{"issue":"23","key":"1129_CR16","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1001\/jama.294.23.3019","volume":"294","author":"DF Kelly","year":"2005","unstructured":"Kelly DF, Pollard AJ, Moxon ER (2005) Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. JAMA 294(23):3019\u20133023","journal-title":"JAMA"},{"issue":"1","key":"1129_CR17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/14760584.3.1.77","volume":"3","author":"P Balmer","year":"2004","unstructured":"Balmer P, Borrow R (2004) Serologic correlates of protection for evaluating the response to meningococcal vaccines. Expert Rev Vaccines 3(1):77\u201387","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"1129_CR18","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.267.11.1489","volume":"267","author":"Y Schlesinger","year":"1992","unstructured":"Schlesinger Y, Granoff DM (1992) Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. JAMA 267(11):1489\u20131494","journal-title":"JAMA"},{"issue":"52","key":"1129_CR19","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1016\/j.vaccine.2008.09.052","volume":"26","author":"A Meerveld-Eggink","year":"2008","unstructured":"Meerveld-Eggink A, de Weerdt O, Rijkers GT, van Velzen-Blad H, Biesma DH (2008) Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Vaccine 26(52):6975\u20136979","journal-title":"Vaccine"},{"issue":"3","key":"1129_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/CVI.00364-08","volume":"16","author":"RM Voer de","year":"2009","unstructured":"de Voer RM, Schepp RM, Versteegh FG, van der Klis FR, Berbers GA (2009) Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay. Clin Vaccine Immunol 16(3):433\u2013436","journal-title":"Clin Vaccine Immunol"},{"issue":"50","key":"1129_CR21","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1016\/j.vaccine.2009.09.082","volume":"27","author":"RM Voer de","year":"2009","unstructured":"de Voer RM, van der Klis FR, Engels CW, Schepp RM, van de Kassteele J, Sanders EA et al (2009) Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults. Vaccine 27(50):6974\u20136982","journal-title":"Vaccine"},{"issue":"2","key":"1129_CR22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/CDLI.11.2.272-279.2004","volume":"11","author":"G Lal","year":"2004","unstructured":"Lal G, Balmer P, Joseph H, Dawson M, Borrow R (2004) Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135. Clin Diagn Lab Immunol 11(2):272\u2013279","journal-title":"Clin Diagn Lab Immunol"},{"issue":"8","key":"1129_CR23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1128\/CVI.00478-07","volume":"15","author":"RM Voer de","year":"2008","unstructured":"de Voer RM, van der Klis FR, Engels CW, Rijkers GT, Sanders EA, Berbers GA (2008) Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides. Clin Vaccine Immunol 15(8):1188\u20131193","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"1129_CR24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/CDLI.2.2.132-137.1995","volume":"2","author":"PK Holder","year":"1995","unstructured":"Holder PK, Maslanka SE, Pais LB, Dykes J, Plikaytis BD, Carlone GM (1995) Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin Diagn Lab Immunol 2(2):132\u2013137","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"1129_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CDLI.11.1.1-5.2004","volume":"11","author":"H Joseph","year":"2004","unstructured":"Joseph H, Balmer P, Bybel M, Papa T, Ryall R, Borrow R (2004) Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera. Clin Diagn Lab Immunol 11(1):1\u20135","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"1129_CR26","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1086\/515298","volume":"177","author":"M Anttila","year":"1998","unstructured":"Anttila M, Eskola J, Ahman H, K\u00e4yhty H (1998) Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. J Infect Dis 177(6):1614\u20131621","journal-title":"J Infect Dis"},{"issue":"2","key":"1129_CR27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.22399","volume":"56","author":"E Zonneveld-Huijssoon","year":"2007","unstructured":"Zonneveld-Huijssoon E, Ronaghy A, Van Rossum MA, Rijkers GT, van der Klis FR, Sanders EA et al (2007) Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis. Arthritis Rheum 56(2):639\u2013646","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1129_CR28","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","volume":"70","author":"M Burrage","year":"2002","unstructured":"Burrage M, Robinson A, Borrow R, Andrews N, Southern J, Findlow J et al (2002) Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection. Infect Immun 70(9):4946\u20134954","journal-title":"Infect Immun"},{"issue":"7\u20138","key":"1129_CR29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0264-410X(99)00276-5","volume":"18","author":"P Richmond","year":"1999","unstructured":"Richmond P, Goldblatt D, Fusco PC, Fusco JD, Heron I, Clark S et al (1999) Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine 18(7\u20138):641\u2013646","journal-title":"Vaccine"},{"issue":"1","key":"1129_CR30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","volume":"183","author":"P Richmond","year":"2001","unstructured":"Richmond P, Borrow R, Goldblatt D, Findlow J, Martin S, Morris R et al (2001) Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis 183(1):160\u2013163","journal-title":"J Infect Dis"},{"issue":"1","key":"1129_CR31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/IAI.72.1.332-337.2004","volume":"72","author":"P Balmer","year":"2004","unstructured":"Balmer P, Falconer M, McDonald P, Andrews N, Fuller E, Riley C et al (2004) Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals. Infect Immun 72(1):332\u2013337","journal-title":"Infect Immun"},{"issue":"9","key":"1129_CR32","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/606046","volume":"49","author":"D Goldblatt","year":"2009","unstructured":"Goldblatt D, Southern J, Andrews N, Ashton L, Burbidge P, Woodgate S et al (2009) The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50\u201380\u00a0years. Clin Infect Dis 49(9):1318\u20131325","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1129_CR33","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","volume":"180","author":"G Blanchard Rohner","year":"2008","unstructured":"Blanchard Rohner G, Snape MD, Kelly DF, John T, Morant A, Yu LM et al (2008) The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response. J Immunol 180(4):2165\u20132173","journal-title":"J Immunol"},{"issue":"6","key":"1129_CR34","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/CDLI.11.6.1100-1104.2004","volume":"11","author":"J Southern","year":"2004","unstructured":"Southern J, Deane S, Ashton L, Borrow R, Goldblatt D, Andrews N et al (2004) Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults. Clin Diagn Lab Immunol 11(6):1100\u20131104","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"1129_CR35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/338474","volume":"185","author":"D Goldblatt","year":"2002","unstructured":"Goldblatt D, Borrow R, Miller E (2002) Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults. J Infect Dis 185(3):397\u2013400","journal-title":"J Infect Dis"},{"issue":"6","key":"1129_CR36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/314750","volume":"179","author":"WA Hutchins","year":"1999","unstructured":"Hutchins WA, Carlone GM, Westerink MA (1999) Elderly immune response to a TI-2 antigen: heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide. J Infect Dis 179(6):1433\u20131440","journal-title":"J Infect Dis"},{"issue":"4","key":"1129_CR37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1128\/CVI.13.4.507-510.2006","volume":"13","author":"H Findlow","year":"2006","unstructured":"Findlow H, Southern J, Mabey L, Balmer P, Heyderman RS, Auckland C et al (2006) Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine. Clin Vaccine Immunol 13(4):507\u2013510","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"1129_CR38","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.4049\/jimmunol.139.6.1999","volume":"139","author":"O M\u00e4kel\u00e4","year":"1987","unstructured":"M\u00e4kel\u00e4 O, Mattila P, Rautonen N, Sepp\u00e4l\u00e4 I, Eskola J, K\u00e4yhty H (1987) Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid). J Immunol 139(6):1999\u20132004","journal-title":"J Immunol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1129-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-010-1129-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1129-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T16:14:58Z","timestamp":1685895298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-010-1129-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,24]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1007\/s10096-010-1129-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,24]]}}}